{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:40:53Z","timestamp":1792978853120,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T00:00:00Z","timestamp":1512000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"UK Engineering and Physical Sciences Research Council","doi-asserted-by":"crossref","award":["(EP\/K502340\/1)"],"award-info":[{"award-number":["(EP\/K502340\/1)"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nanomerics Ltd.","award":["(NM12TSB-NPP)"],"award-info":[{"award-number":["(NM12TSB-NPP)"]}],"id":[{"id":"https:\/\/ror.org\/00ff3ex79","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["(16939-124181)"],"award-info":[{"award-number":["(16939-124181)"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jconrel.2017.11.041","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T13:30:25Z","timestamp":1511789425000},"page":"135-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["Nanoparticulate peptide delivery exclusively to the brain produces tolerance free analgesia"],"prefix":"10.1016","volume":"270","author":[{"given":"Lisa","family":"Godfrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Iannitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie L.","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Moger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Imbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Porreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Soundararajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Lalatsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas G.","family":"Sch\u00e4tzlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijeoma F.","family":"Uchegbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.11.041_bb0005","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1021\/nn305193d","article-title":"Nanofiber-based delivery of therapeutic peptides to the brain","volume":"7","author":"Mazza","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.11.041_bb0010","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1007\/s11095-012-0915-1","article-title":"Intranasal treatment of central nervous system dysfunction in humans","volume":"30","author":"Chapman","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0090-9556(25)08486-7","article-title":"Inhibition of leucine enkephalin metabolism in rat blood, plasma and tissues in vitro by an aminoboronic acid derivative","volume":"18","author":"Hussain","year":"1990","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0020","series-title":"Neuropeptides and Neural Transmission","article-title":"Enkephalins, endorphins and their receptors","author":"Kosterlitz","year":"1980"},{"key":"10.1016\/j.jconrel.2017.11.041_bb0025","first-page":"440","article-title":"Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications","volume":"178","author":"Toll","year":"1998","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drugalcdep.2012.01.013","article-title":"Opioid receptor expression in human brain and peripheral tissues using absolute quantitative real-time RT-PCR","volume":"124","author":"Peng","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.jconrel.2017.11.041_bb0040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrd3624","article-title":"The neuropathic pain market","volume":"11","author":"Nightingale","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0045","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jpain.2006.02.003","article-title":"Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain","volume":"7","author":"Portenoy","year":"2006","journal-title":"J. Pain"},{"key":"10.1016\/j.jconrel.2017.11.041_bb0050","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1124\/pr.112.007138","article-title":"Mu opioids and their receptors: evolution of a concept","volume":"65","author":"Pasternak","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0055","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.jconrel.2017.11.041_bb0060","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/BF00964980","article-title":"Mechanisms of leu-enkephalin hydrolysis in human plasma","volume":"10","author":"Roscetti","year":"1985","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0304-4165(87)90122-X","article-title":"Metabolism of opioid peptides by cerebral microvascular aminopeptidase M","volume":"923","author":"Churchill","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2017.11.041_bb0070","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/mp400680d","article-title":"Strategies to deliver peptide drugs to the brain","volume":"11","author":"Lalatsa","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0075","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1021\/mp300068j","article-title":"Delivery of peptides to the blood and brain after oral uptake of quaternary ammonium palmitoyl glycol chitosan nanoparticles","volume":"9","author":"Lalatsa","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0080","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1021\/mp300009u","article-title":"A prodrug nanoparticle approach for the oral delivery of a hydrophilic peptide, leucine(5)-enkephalin, to the brain","volume":"9","author":"Lalatsa","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0085","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrd3673","article-title":"Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain","volume":"11","author":"Roques","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1211\/0022357022539","article-title":"Is nose-to-brain transport of drugs in man a reality?","volume":"56","author":"Illum","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0095","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0091-6749(95)70230-X","article-title":"Human nasal mucosal carboxypeptidase: activity, location, and release","volume":"96","author":"Ohkubo","year":"1995","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0100","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1124\/dmd.105.005769","article-title":"Expression of cytochrome p450 and other biotransformation genes in fetal and adult human nasal mucosa","volume":"33","author":"Zhang","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejpb.2014.03.004","article-title":"Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules","volume":"88","author":"Fortuna","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0110","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijpharm.2007.01.047","article-title":"Nasal administration of an angiotensin antagonist in the rat model: effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems","volume":"338","author":"Charlton","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2474-12-134","article-title":"Pain-related sensory innervation in monoiodoacetate-induced osteoarthritis in rat knees that gradually develops neuronal injury in addition to inflammatory pain","volume":"12","author":"Orita","year":"2011","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0304-3959(92)90041-9","article-title":"An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat","volume":"50","author":"Kim","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.jconrel.2017.11.041_bb0130","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/nn.2407","article-title":"Unmasking the tonic-aversive state in neuropathic pain","volume":"12","author":"King","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0135","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jpain.2013.02.011","article-title":"Descending facilitation maintains long-term spontaneous neuropathic pain","volume":"14","author":"Wang","year":"2013","journal-title":"J. pain"},{"key":"10.1016\/j.jconrel.2017.11.041_bb0140","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/jbio.201200006","article-title":"Exploring uptake mechanisms of oral nanomedicines using multimodal nonlinear optical microscopy","volume":"5","author":"Garrett","year":"2012","journal-title":"J. Biophotonics"},{"key":"10.1016\/j.jconrel.2017.11.041_bb0145","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/260625a0","article-title":"Analgesia induced in vivo by central administration of enkephalin in rat","volume":"260","author":"Belluzzi","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.11.041_bb0150","author":"European Medicines Agency"},{"key":"10.1016\/j.jconrel.2017.11.041_bb0155","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/jrs.3156","article-title":"Imaging cortical vasculature with stimulated Raman scattering and two photon photothermal lensing microscopy","volume":"43","author":"Moger","year":"2012","journal-title":"J. Raman Spectrosc."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/jcbfm.2014.215","article-title":"Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration","volume":"35","author":"Lochhead","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0165","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1021\/mp100029t","article-title":"Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures","volume":"7","author":"Johnson","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0170","doi-asserted-by":"crossref","first-page":"31732","DOI":"10.1038\/srep31732","article-title":"Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery","volume":"6","author":"Kumar","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0175","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/mp500527x","article-title":"Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles","volume":"12","author":"Serrano","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0180","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1073\/pnas.74.11.4927","article-title":"Binding of the endogenous nonpeptide morphine-like compound to opiate receptors","volume":"74","author":"Blume","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0185","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijbiomac.2013.06.041","article-title":"Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery","volume":"61","author":"Kumar","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1021\/mp200469a","article-title":"Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles","volume":"9","author":"Siew","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0195","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0006-8993(86)90243-X","article-title":"Antagonism of stress-induced analgesia by quaternary naloxone","volume":"380","author":"Chance","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0200","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00000542-197605000-00008","article-title":"Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action","volume":"44","author":"Ngai","year":"1976","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jconrel.2017.11.041_bb0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1124\/jpet.113.204313","article-title":"Mechanisms that underlie mu-opioid receptor agonist-induced constipation: differential involvement of mu-opioid receptor sites and responsible regions","volume":"347","author":"Mori","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2005.08.008","article-title":"H-3 alvimopan binding to the mu opioid receptor: comparative binding kinetics of opioid antagonists","volume":"520","author":"Cassel","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0215","doi-asserted-by":"crossref","first-page":"E503","DOI":"10.36076\/ppj.2014\/17\/E503","article-title":"Opioid tolerance\u2014a predictor of increased length of stay and higher readmission rates","volume":"17","author":"Gulur","year":"2014","journal-title":"Pain Physician"},{"key":"10.1016\/j.jconrel.2017.11.041_bb0220","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1155\/2015\/897491","article-title":"Opioid use among same-day surgery patients: prevalence, management and outcomes","volume":"20","author":"Wilson","year":"2015","journal-title":"Pain Res. Manag."},{"key":"10.1016\/j.jconrel.2017.11.041_bb0225","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jconrel.2017.11.041_bb0230","doi-asserted-by":"crossref","first-page":"16459","DOI":"10.1523\/JNEUROSCI.3748-10.2010","article-title":"Ligand-directed trafficking of the delta-opioid receptor in vivo: two paths toward analgesic tolerance","volume":"30","author":"Pradhan","year":"2010","journal-title":"J. Neurosci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917310489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917310489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T11:33:29Z","timestamp":1751024009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917310489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":46,"alternative-id":["S0168365917310489"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.11.041","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticulate peptide delivery exclusively to the brain produces tolerance free analgesia","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.11.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}